Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy.

cerebral amyloid angiopathy colocalization cortical superficial siderosis magnetic-resonance-imaging positron-emission-tomography topology β-amyloid

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2021
Historique:
received: 29 09 2021
accepted: 20 12 2021
entrez: 21 2 2022
pubmed: 22 2 2022
medline: 22 2 2022
Statut: epublish

Résumé

This is a cross-sectional study to evaluate whether β-amyloid-(Aβ)-PET positivity and cortical superficial siderosis (cSS) in patients with cerebral amyloid angiopathy (CAA) are regionally colocalized. Ten patients with probable or possible CAA (73.3 ± 10.9 years, 40% women) underwent MRI examination with a gradient-echo-T2*-weighted-imaging sequence to detect cSS and cSS- and Aβ-PET positivity did not indicate similarity of their regional patterns, despite a minor association between the frequency of Aβ-positive patients and the frequency of cSS-positive patients within individual regions ( In this cross-sectional study, cSS and Aβ-PET positivity did not show regional association in patients with CAA and deserve further exploitation in longitudinal designs. In clinical routine, a specific cross-sectional evaluation of Aβ-PET in cSS-positive regions is probably not useful for visual reading of Aβ-PETs in patients with CAA.

Identifiants

pubmed: 35185518
doi: 10.3389/fnagi.2021.786143
pmc: PMC8851392
doi:

Types de publication

Journal Article

Langues

eng

Pagination

786143

Informations de copyright

Copyright © 2022 Finze, Wahl, Janowitz, Buerger, Linn, Rominger, Stöcklein, Bartenstein, Wollenweber, Catak and Brendel.

Déclaration de conflit d'intérêts

MB received speaker honoraria from GE Healthcare, Roche and LMI and is an advisor of LMI. AR and PB received speaker honoraria from GE Healthcare. JL received speaker honoraria from Bayer Vital GmbH and is an advisory board member of Mediaire GmbH and Biogen GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Alzheimers Dement. 2015 Aug;11(8):964-74
pubmed: 25824567
Hum Brain Mapp. 2003 Aug;19(4):224-47
pubmed: 12874777
JAMA Neurol. 2020 Nov 1;77(11):1408-1419
pubmed: 33165511
JAMA. 2011 Jan 19;305(3):275-83
pubmed: 21245183
BMC Neurol. 2020 May 8;20(1):174
pubmed: 32384876
Neurology. 2019 Jan 15;92(3):e253-e262
pubmed: 30568001
Neurology. 1996 Jun;46(6):1592-6
pubmed: 8649554
Neurology. 2019 Feb 19;92(8):e792-e801
pubmed: 30674596
J Comput Assist Tomogr. 1994 Mar-Apr;18(2):192-205
pubmed: 8126267
Lancet Neurol. 2011 May;10(5):424-35
pubmed: 21481640
Neuropathol Appl Neurobiol. 2011 Feb;37(1):75-93
pubmed: 20946241
AJNR Am J Neuroradiol. 2008 Jan;29(1):184-6
pubmed: 17947366
J Nucl Med. 2013 Sep;54(9):1570-6
pubmed: 23940304
JAMA Neurol. 2015 Mar;72(3):287-94
pubmed: 25622185
J Nucl Med. 2022 Jan;63(1):117-124
pubmed: 34016733
Neurology. 2014 Feb 25;82(8):698-704
pubmed: 24477113
BMC Neurol. 2009 Jan 13;9:3
pubmed: 19144113
AJNR Am J Neuroradiol. 2010 Jan;31(1):5-14
pubmed: 19729538
Neurology. 2021 Nov 2;97(18):e1809-e1822
pubmed: 34531298
Lancet. 2009 May 9;373(9675):1632-44
pubmed: 19427958
Neurology. 2016 Sep 13;87(11):1110-7
pubmed: 27534713
Front Immunol. 2019 Jul 04;10:1534
pubmed: 31333665
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):124-37
pubmed: 22056963
Ann Neurol. 2011 Feb;69(2):320-7
pubmed: 21387377
N Engl J Med. 2000 Jan 27;342(4):240-5
pubmed: 10648765
Neurology. 2013 Aug 13;81(7):626-32
pubmed: 23864315
J Neurol Sci. 1993 Jun;116(2):135-41
pubmed: 8336159
Neurology. 2021 Nov 2;97(18):e1799-e1808
pubmed: 34504022
J Neurol. 2013 Jan;260(1):176-81
pubmed: 22820723
Neurology. 2010 Apr 27;74(17):1346-50
pubmed: 20421578
J Neurol Sci. 2007 Jun 15;257(1-2):49-55
pubmed: 17306303
Stroke. 1987 Mar-Apr;18(2):311-24
pubmed: 3551211
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
Brain. 2020 Dec 5;143(11):3343-3351
pubmed: 32935842
Neurobiol Aging. 2009 Dec;30(12):1936-48
pubmed: 18359131
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Neurology. 2001 Feb 27;56(4):537-9
pubmed: 11222803
Neurology. 2013 Nov 5;81(19):1666-73
pubmed: 24107862
N Engl J Med. 2001 May 10;344(19):1450-60
pubmed: 11346811
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1287-1298
pubmed: 30937462
Stroke. 1983 Nov-Dec;14(6):924-8
pubmed: 6658996
Int J Stroke. 2014 Apr;9(3):387-92
pubmed: 23834337
Dement Geriatr Cogn Disord. 2006;22(1):8-14
pubmed: 16645275
J Neuropathol Exp Neurol. 2000 Sep;59(9):768-73
pubmed: 11005257
Neuroimage. 2008 Apr 1;40(2):672-684
pubmed: 18234511
Arch Neurol. 1995 Jul;52(7):702-8
pubmed: 7619027
Neuroimage. 2015 Mar;108:450-9
pubmed: 25482269
Case Rep Neurol. 2020 Jun 29;12(2):232-237
pubmed: 32774280

Auteurs

Anika Finze (A)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Hannes Wahl (H)

Department of Neuroradiology, University Hospital of Dresden, Carl Gustav Carus University Dresden, Dresden, Germany.

Daniel Janowitz (D)

Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.

Katharina Buerger (K)

Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.

Jennifer Linn (J)

Department of Neuroradiology, University Hospital of Dresden, Carl Gustav Carus University Dresden, Dresden, Germany.

Axel Rominger (A)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Sophia Stöcklein (S)

Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Frank Arne Wollenweber (FA)

Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.

Cihan Catak (C)

Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.

Matthias Brendel (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Classifications MeSH